Publication: American Journal of Managed Care
Dr. Scott Paulson, medical oncologist with Texas Oncology–Baylor Charles A. Sammons Cancer Center, discusses current challenges in the treatment landscape of neuroendocrine tumors. He says the biggest challenge we have right now is figuring out how to sequence all of these therapies and how to pick the right patient to sequence those treatments.
The biggest challenge we have right now is how to sequence all of these therapies and how to pick the right patient to sequence those treatments, explained Scott Paulson, MD, co-director of the Gastrointestinal Research Program for The US Oncology Network, medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center.
Read the full story at American Journal of Managed Care.